subscribeSubscribe
price-trendAsk Us
New Data Analysis Supports GOCOVRI for Motor Complications for People With PD

New Data Analysis Supports GOCOVRI for Motor Complications for People With PD
BUSINESSWIRE
10 Jun 2021
Share Share
Adamas` Parkinson`s drug gets US marketing authorisation for second indication

Adamas` Parkinson`s drug gets US marketing authorisation for second indication
PHARMAFILE
01 Feb 2021
Share Share
Adamas announces issuance of new U.S. patent for GOCOVRI

Adamas announces issuance of new U.S. patent for GOCOVRI
GLOBENEWSWIRE
13 May 2020
Share Share
Gocovri™ (Amantadine) : Adamas Pharma, v. Sandoz

Gocovri™ (Amantadine) : Adamas Pharma, v. Sandoz
PATENT LITIGATION
10 May 2018
Share Share